Stock Track | UnitedHealth Soars 5.39% in Pre-Market on Strong Q2 Earnings Beat and Raised Guidance

Stock Track

Jul 16

UnitedHealth's stock surged 5.39% in pre-market trading following the release of its second-quarter 2026 financial results, which significantly exceeded analyst expectations across key metrics.

The healthcare giant reported adjusted earnings per share of $6.38, beating the consensus estimate of $4.90. Revenue came in at $112 billion, surpassing expectations of approximately $110.85 billion. A critical measure of cost efficiency, the medical cost ratio, improved to 86.7%, better than the anticipated 88.47%.

Bolstered by these results, the company raised its full-year 2026 adjusted earnings per share guidance to a range of $19.50 to $20.00, up from the previous forecast and above the analyst estimate of $18.47. The strong performance was attributed to effective medical cost controls, improved operations in its Optum health services segment, and strategic plan design changes.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1137005763"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1137005763\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1137005763?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-16 18:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1137005763","market":"sg","top_or_hot":-1,"title":"Stock Track | UnitedHealth Soars 5.39% in Pre-Market on Strong Q2 Earnings Beat and Raised Guidance","media":"Stock Track","content":"<p>UnitedHealth's stock surged 5.39% in pre-market trading following the release of its second-quarter 2026 financial results, which significantly exceeded analyst expectations across key metrics.</p><p>The healthcare giant reported adjusted earnings per share of $6.38, beating the consensus estimate of $4.90. Revenue came in at $112 billion, surpassing expectations of approximately $110.85 billion. A critical measure of cost efficiency, the medical cost ratio, improved to 86.7%, better than the anticipated 88.47%.</p><p>Bolstered by these results, the company raised its full-year 2026 adjusted earnings per share guidance to a range of $19.50 to $20.00, up from the previous forecast and above the analyst estimate of $18.47. The strong performance was attributed to effective medical cost controls, improved operations in its Optum health services segment, and strategic plan design changes.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | UnitedHealth Soars 5.39% in Pre-Market on Strong Q2 Earnings Beat and Raised Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | UnitedHealth Soars 5.39% in Pre-Market on Strong Q2 Earnings Beat and Raised Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-07-16 18:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>UnitedHealth's stock surged 5.39% in pre-market trading following the release of its second-quarter 2026 financial results, which significantly exceeded analyst expectations across key metrics.</p><p>The healthcare giant reported adjusted earnings per share of $6.38, beating the consensus estimate of $4.90. Revenue came in at $112 billion, surpassing expectations of approximately $110.85 billion. A critical measure of cost efficiency, the medical cost ratio, improved to 86.7%, better than the anticipated 88.47%.</p><p>Bolstered by these results, the company raised its full-year 2026 adjusted earnings per share guidance to a range of $19.50 to $20.00, up from the previous forecast and above the analyst estimate of $18.47. The strong performance was attributed to effective medical cost controls, improved operations in its Optum health services segment, and strategic plan design changes.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"UNH","symbol_name":"联合健康","start_time":0,"source_url":"","article_id":"1137005763","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1137005763","pubTimestamp":1784196122,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"UnitedHealth's stock surged 5.39% in pre-market trading following the release of its second-quarter 2026 financial results, which significantly exceeded analyst expectations across key metrics.The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"UNH":"联合健康"},"translate_title":"股票跟踪 | UnitedHealth 第二季度盈利强劲并上调指引，盘前股价飙升 5.39%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"UNH":1},"content_text":"UnitedHealth's stock surged 5.39% in pre-market trading following the release of its second-quarter 2026 financial results, which significantly exceeded analyst expectations across key metrics.The healthcare giant reported adjusted earnings per share of $6.38, beating the consensus estimate of $4.90. Revenue came in at $112 billion, surpassing expectations of approximately $110.85 billion. A critical measure of cost efficiency, the medical cost ratio, improved to 86.7%, better than the anticipated 88.47%.Bolstered by these results, the company raised its full-year 2026 adjusted earnings per share guidance to a range of $19.50 to $20.00, up from the previous forecast and above the analyst estimate of $18.47. The strong performance was attributed to effective medical cost controls, improved operations in its Optum health services segment, and strategic plan design changes.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}